Form 4 for EW Edwards Lifesciences
Accepted 2026-03-11 00:00:00 ET · period of report 2026-03-11 · accession 0001225208-26-003539 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2026-03-11 | 2026-03-11 | EW | Ullem Scott B. | CFO, CVP | S - Sale+OE | $84.92 | -13.0K | 47.6K | -21% | -$1.10M |
| D | 2026-03-11 | 2026-03-11 | EW | Ullem Scott B. | CFO, CVP | M - OptEx | $59.26 | +13.0K | 52.7K | +33% | +$770.4K |
| D | 2026-03-11 | 2026-03-11 | EW | Ullem Scott B. | CFO, CVP | M - OptEx | $0.00 | -13.0K | 26.0K | -33% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-03-11 | S | D | 7,901 | $85.21 | 39,699 | D | — | — | (F3) This transaction was executed in multiple trades at prices ranging from $84.865 to $85.790. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, uponrequest by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected. |
| 2 | Common | Common Stock | 2026-03-11 | S | D | 5,099 | $84.46 | 47,600 | D | — | — | (F2) This transaction was executed in multiple trades at prices ranging from $83.865 to $84.860. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, uponrequest by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected. |
| 3 | Common | Common Stock | 2026-03-11 | M | A | 13,000 | $59.26 | 52,699 | D | — | — | |
| 4 | Derivative | Employee Stock Option (Right to Acquire) | 2026-03-11 | M | D | 13,000 | $0.00 | 26,000 | D | $59.26 · 2020-05-08 to 2026-05-07 | 13,000 Common Stock |